Department of Endocrinology, Diabetes and Metabolism, School of Medicine, Fujita Health University, Toyoake, Aichi, 470-1192, Japan.
Division of Gene Regulation, Oncology Innovation Center, Fujita Health University, Toyoake, Aichi, 470-1192, Japan.
Free Radic Biol Med. 2024 Oct;223:458-472. doi: 10.1016/j.freeradbiomed.2024.08.019. Epub 2024 Aug 21.
Hyponatremia is the most common clinical electrolyte disorder. Chronic hyponatremia has been recently reported to be associated with falls, fracture, osteoporosis, neurocognitive impairment, and mental manifestations. In the treatment of chronic hyponatremia, overly rapid correction of hyponatremia can cause osmotic demyelination syndrome (ODS), a central demyelinating disease that is also associated with neurological morbidity and mortality. Using a rat model, we have previously shown that microglia play a critical role in the pathogenesis of ODS. However, the direct effect of rapid correction of hyponatremia on microglia is unknown. Furthermore, the effect of chronic hyponatremia on microglia remains elusive. Using microglial cell lines BV-2 and 6-3, we show here that low extracellular sodium concentrations (36 mmol/L decrease; LS) suppress Nos2 mRNA expression and nitric oxide (NO) production of microglia. On rapid correction of low sodium concentrations, NO production was significantly increased in both cells, suggesting that acute correction of hyponatremia partly directly contributes to increased Nos2 mRNA expression and NO release in ODS pathophysiology. LS also suppressed expression and nuclear translocation of nuclear factor of activated T cells-5 (NFAT5), a transcription factor that regulates the expression of genes involved in osmotic stress. Furthermore, overexpression of NFAT5 significantly increased Nos2 mRNA expression and NO production in BV-2 cells. Expressions of Nos2 and Nfat5 mRNA were also modulated in microglia isolated from cerebral cortex in chronic hyponatremia model mice. These data indicate that LS modulates microglial NO production dependent on NFAT5 and suggest that microglia contribute to hyponatremia-induced neuronal dysfunctions.
低钠血症是最常见的临床电解质紊乱。最近有报道称,慢性低钠血症与跌倒、骨折、骨质疏松症、认知功能障碍和精神表现有关。在慢性低钠血症的治疗中,过快纠正低钠血症可导致渗透性脱髓鞘综合征(ODS),这是一种中枢脱髓鞘疾病,也与神经发病率和死亡率有关。我们之前使用大鼠模型表明,小胶质细胞在 ODS 的发病机制中起关键作用。然而,过快纠正低钠血症对小胶质细胞的直接影响尚不清楚。此外,慢性低钠血症对小胶质细胞的影响仍不清楚。我们使用小胶质细胞系 BV-2 和 6-3 表明,低细胞外钠离子浓度(降低 36mmol/L;LS)抑制小胶质细胞的 Nos2 mRNA 表达和一氧化氮(NO)产生。在快速纠正低钠浓度时,两种细胞的 NO 产生均显著增加,这表明急性纠正低钠血症部分直接导致 ODS 病理生理学中 Nos2 mRNA 表达和 NO 释放增加。LS 还抑制了激活 T 细胞的核因子-5(NFAT5)的表达和核易位,NFAT5 是一种调节参与渗透胁迫的基因表达的转录因子。此外,NFAT5 的过表达显著增加了 BV-2 细胞中 Nos2 mRNA 的表达和 NO 的产生。慢性低钠血症模型小鼠大脑皮质分离的小胶质细胞中 Nos2 和 Nfat5 mRNA 的表达也受到调节。这些数据表明,LS 调节小胶质细胞的 NO 产生依赖于 NFAT5,并表明小胶质细胞有助于低钠血症引起的神经元功能障碍。